Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|BNT411||BNT 411|BNT-411||BNT411 is a TLR7 agonist, which activates B cells and CD8-positive T-lymphocytes as well as innate immune cells, potentially resulting in antitumor activity (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04101357||Phase Ib/II||BNT411 Atezolizumab + BNT411 + Carboplatin + Etoposide||Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411||Recruiting||USA||3|